Effects of Long-term Dapagliflozin Treatment on Hemorheology, Leukocyte Activation and Oxidative Stress - Effects of Long-term Dapagliflozin Treatment on Hemorheology, Leukocyte Activation and Oxidative Stress

Hepatocrit was increased by about 2% after 16 weeks of dosage of depagliflosin in type 2 diabetes patients, but proved to be inferior in terms of blood fluidity compared to the conventional treatment group. Concerning safety, the attending physician conducted examination data, interviews, etc. at each visit at each visit to continuously check for adverse events and subjective symptoms, and to ensure the safety of subjects through monitoring.